Chapter

Discussion summary: Getting the right medicine to patients

Timothy J Steiner and Glen D Solomon

in Headache care, research and education worldwide

Published on behalf of Oxford University Press

Published in print May 2010 | ISBN: 9780199584680
Published online November 2012 | e-ISBN: 9780191753435 | DOI: http://dx.doi.org/10.1093/med/9780199584680.003.021

Series: Frontiers in Headache Research Series

Discussion summary: Getting the right medicine to patients

More Like This

Show all results sharing these subjects:

  • Neurology
  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Preview

Good headache care is not achieved solely by the appropriate use of effective drugs but, for most people with troublesome headache, ‘getting the right medicine’ is an important part of it. Sadly, many fail to receive anything close to the right medicine. In large parts of the world, the right medicine is simply not available. In other parts, the problem is access rather than availability, often with the existence of multiple barriers. Before discussing these issues further, some thought must be given to what is meant by the ‘right medicine’.This chapter provides a brief summary of the section as a whole, in which three presenters consider key factors affecting availability, still with the focus on triptans as the clearest exemplar of issues that probably apply to some extent to all drugs for headache.

Chapter.  1460 words. 

Subjects: Neurology ; Clinical Pharmacology and Therapeutics

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.